In article number 1705436, Shaobing Zhou, Zi Chen, and co-workers develop an acid-active tumor-targeting nanoplatform with self-reported drug-release capability. This platform has unique features, such as a long blood circulation through shielding of the cationic charges of trans-activating transcriptional activator (TAT), an enhanced cellular internalization by regenerating the original TAT in acidic tumor tissue, and a self-reported drug release via the Förster resonance energy transfer (FRET) signal triggered by the intracellular reductant.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: